ChiCTR2600126870 clinical trial report covering Bevacizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07652294 clinical trial report covering SPY-003, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07654530 clinical trial report covering Ipilimumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07652658 clinical trial report covering AZD-8965, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07652879 clinical trial report covering Cyclophosphamide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07654283 clinical trial report covering AHB-137, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07654400 clinical trial report covering BL-M14D1, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07654465 clinical trial report covering Rituximab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07654231 clinical trial report covering Colchicine, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07662863 clinical trial report covering Sacituzumab tirumotecan, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07660172 clinical trial report covering Ianalumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07662473 clinical trial report covering PVR-DXd, Phase 2, endpoints, sponsor, geography, readout timing and development white space.